United States of America et al v. Organon USA Inc et al

1:07-cv-12153

July 03, 2012
Omnicare Asks For Protection From Expected FCA Suit Flood

Nursing home pharmacy company Omnicare Inc. asked a Massachusetts federal judge Monday to reconsider her refusal to shield it from kickback allegations in a $421 million False Claims Act lawsuit, saying it's being treated differently from other companies and could face virtually endless litigation as a result.
June 04, 2012
Judge Trims $421M Medicaid Kickback Suit Against Organon

A Massachusetts federal judge on Friday pared down a $421 million False Claims Act employee whistleblower case that alleged pharmaceutical company Organon USA Inc. operated a kickback scheme with two long-term care pharmacies to overcharge Medicaid for the company's antidepressant Remeron.
April 03, 2012
Akzo Nobel Escapes $421M Medicaid Kickback Suit

A federal judge agreed on Friday to dismiss a False Claims Act case filed by employee whistleblowers against Akzo Nobel NV, the former parent of Organon USA Inc., a pharmaceutical company accused of operating a kickback scheme that helped overcharge Medicaid by $421 million.
July 08, 2011
Organon, Others Want $421M Medicaid FCA Suit Tossed

Organon USA Inc., Merck & Co. Inc. and Schering Plough Corp. asked a Massachusetts federal court Thursday to dismiss a False Claims Act suit by ex-Organon employees accusing them of concocting a kickback scheme that helped overcharge the government by $421 million.